RxDoctor Payments Data

Eric Graves, MD

Family Medicine · Montgomery, ALNPI 1871574517

Payments from drug & device makers

$1,346in general payments, 2019–2025

Across 84 payments — averaging $16.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$287
  • Novo Nordisk$285
  • GSK$188
  • Johnson & Johnson$122
  • Abbott$92
  • Amgen$70
  • plus $302 from 12 others

What the payments were for

  • Food & beverage$1,346100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,346 in reported general payments places this provider in the 60th percentile of 1,680 family medicine providers in Alabama.

See all family medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$138,872
Medicare patients
208
Services billed
6,117

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide51$47,567
Tresiba Flextouch U-200Insulin Degludec17$28,082
XareltoRivaroxaban25$27,060
MounjaroTirzepatide21$22,019
JanuviaSitagliptin Phosphate28$20,496
EliquisApixaban16$17,443
LinzessLinaclotide25$17,046
FarxigaDapagliflozin Propanediol11$12,053
Atorvastatin Calcium328$5,522
SymbicortBudesonide/Formoterol Fumarate16$5,367
Levothyroxine Sodium227$4,718
Breo ElliptaFluticasone/Vilanterol12$4,478
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$4,340
Omeprazole203$4,123
Simvastatin272$3,868

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$285$47,56751 claims
Johnson & JohnsonXarelto$122$27,06025 claims
Lilly USA, LLCMounjaro$34$22,01921 claims
MerckJanuvia$23$20,49628 claims
AbbVieLinzess, Synthroid$287$19,64259 claims
PfizerEliquis$31$17,44316 claims
AstraZenecaFarxiga, Symbicort$13$17,42127 claims
GSKBreo Ellipta$188$4,47812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,680 family medicine providers in Alabama.

Other family medicine in Montgomery

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →